SKIL and prostate carcinoma: In this study, we performed transcriptome and low-coverage whole genome sequencing on 28 untreated and 13 castration resistant prostate cancers, and identified a new prostate cancer subtype characterized by activating rearrangements of the SMAD inhibitor SKIL.